Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,355 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association between metabolic syndrome severity score and cardiovascular disease: results from a longitudinal cohort study on Chinese adults.
Lin JJ, Dai PY, Zhang J, Guan YQ, Gong WW, Yu M, Fang L, Hu RY, He QF, Li N, Wang LX, Liang MB, Zhong JM. Lin JJ, et al. Among authors: gong ww. Front Endocrinol (Lausanne). 2024 Apr 8;15:1341546. doi: 10.3389/fendo.2024.1341546. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38654930 Free PMC article.
Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial.
Chen Y, Xu Y, Chi Y, Sun T, Gao Y, Dou X, Han Z, Xue F, Li H, Liu W, Liu X, Dong H, Fu R, Ju M, Dai X, Wang W, Ma Y, Song Z, Gu J, Gong W, Yang R, Zhang L. Chen Y, et al. Among authors: gong w. Signal Transduct Target Ther. 2024 Apr 23;9(1):102. doi: 10.1038/s41392-024-01793-5. Signal Transduct Target Ther. 2024. PMID: 38653983 Free PMC article. Clinical Trial.
Investigating the impact of empagliflozin on the retina of diabetic mice.
Chen J, Zhang S, You Y, Hu S, Tang J, Chen C, Wen W, Tang T, Yu Q, Tong X, Wang C, Zhao W, Fu X, Zhang X, Wang M, Gong W. Chen J, et al. Among authors: gong w. Eur J Ophthalmol. 2024 Apr 23:11206721241247585. doi: 10.1177/11206721241247585. Online ahead of print. Eur J Ophthalmol. 2024. PMID: 38653578
Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trial.
Xu L, Chen J, Liu C, Song X, Zhang Y, Zhao H, Yan S, Jia W, Wu Z, Guo Y, Yang J, Gong W, Ma Y, Yang X, Gao Z, Zhang N, Zheng X, Li M, Su D, Chen M. Xu L, et al. Among authors: gong w. BMC Med. 2024 Apr 23;22(1):172. doi: 10.1186/s12916-024-03356-5. BMC Med. 2024. PMID: 38650037 Free PMC article.
4,355 results